Virpax Pharmaceuticals, Inc. (VRPX)

NASDAQ: VRPX · IEX Real-Time Price · USD

0.530

+0.029 (5.81%)

At close: Jul 2, 2024, 4:00 PM

0.524

-0.006 (-1.15%)

After-hours: Jul 2, 2024, 6:50 PM EDT

Virpax Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-15.19	-21.65	-12.06	-4.34	-3.31	Upgrade
Share-Based Compensation	0.54	0.75	0.97	1.47	0.68	Upgrade
Other Operating Activities	4.79	3.06	-3.46	1.48	1.5	Upgrade
Operating Cash Flow	-9.85	-17.85	-14.54	-1.38	-1.13	Upgrade
Share Issuance / Repurchase	0	0	52.83	1.38	0.63	Upgrade
Debt Issued / Paid	0	0	-1.5	0.07	0.5	Upgrade
Other Financing Activities	-	-	-	-0.05	-	Upgrade
Financing Cash Flow	0	0	51.33	1.4	1.13	Upgrade
Net Cash Flow	-9.85	-17.85	36.79	0.01	-0.01	Upgrade
Free Cash Flow	-9.85	-17.85	-14.54	-1.38	-1.13	Upgrade
Free Cash Flow Per Share	-8.41	-15.24	-21.78	-4.46	-3.86	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).